Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
national top stories
roche
3
×
boehringer ingelheim
boston blog main
boston top stories
fda
national
novartis
san francisco top stories
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
alexion pharmaceuticals
alnylam pharmaceuticals
aprea therapeutics
arimoclomol
arnold levine
baker brothers
billy dunn
biogen
biotech ipos
boston
cancer
cancer diagnostics
cdg therapeutics
cirina
daiichi sankyo
deals
decheng capital
deerfield capital
diabetic macular edema
dicerna pharamceuticals
drug prices
drug pricing
europe top stories
What
intended
3
×
drug
roche
approved
atrophy
blood
broader
cancer
caught
causing
company
daily
detect
developing
dicerna
disease
evrysdi
eye
fda
files
firms
friday
gene
grail
green
hepatitis
home
investors
ipo
join
life
lights
liquid
medicine
medicines
muscular
new
oral
patients
pay
Language
unset
Current search:
roche
×
intended
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug